RAD 202 receives approval to start Phase 1 therapeutic trial

By 2 days ago2 views

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

Navigating the Indecisive SPY: What Investors Should Know

Top 5 Canadian Mining Stocks This Week: Omineca Jumps 67 Percent

The S&P/TSX Venture Composite Index (INDEXTSI:JX) fell 2.87 percent on the week to close at ...

21Dec2024

Opawica Announces the Closing of Non-Brokered Private Placement

(TheNewswire) December 20th, 2024 Vancouver, B.C. TheNewswire – Opawica Explorations Inc. (TSXV: OPW) (FSE: A2PEAD) ...

Leave a reply Cancel reply

Your email address will not be published. Required fields are marked *

Comment

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.